Literature DB >> 27463701

KIF5A mutations cause an infantile onset phenotype including severe myoclonus with evidence of mitochondrial dysfunction.

Jessica Duis1, Shannon Dean2, Carolyn Applegate3, Amy Harper4, Rui Xiao5, Weimin He5, James D Dollar6, Lisa R Sun2, Marta Biderman Waberski7, Thomas O Crawford2, Ada Hamosh3, Carl E Stafstrom2.   

Abstract

Missense mutations in kinesin family member 5A (KIF5A) cause spastic paraplegia 10. We report on 2 patients with de novo stop-loss frameshift variants in KIF5A resulting in a novel phenotype that includes severe infantile onset myoclonus, hypotonia, optic nerve abnormalities, dysphagia, apnea, and early developmental arrest. We propose that alteration and elongation of the carboxy-terminus of the protein has a dominant-negative effect, causing mitochondrial dysfunction in the setting of an abnormal kinesin "motor." These results highlight the role of expanded testing and whole-exome sequencing in critically ill infants and emphasize the importance of accurate test interpretation. Ann Neurol 2016;80:633-637.
© 2016 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27463701      PMCID: PMC5042851          DOI: 10.1002/ana.24744

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  17 in total

Review 1.  Mitochondrial trafficking in neurons.

Authors:  Thomas L Schwarz
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-06-01       Impact factor: 10.005

Review 2.  Interaction of different proteins with GABAA receptor and their modulatory effect on inhibitory neural transmission leads to epilepsy.

Authors:  Muhammad Faheem; Adeel G Chaudhary; Taha A Kumosani; Mohammad H Al-Qahtani; Muhammad Yasir; Fehmida Bibi; Myeong O Kim; Mahmood Rasool; Muhammad I Naseer
Journal:  CNS Neurol Disord Drug Targets       Date:  2014       Impact factor: 4.388

3.  Unique function of Kinesin Kif5A in localization of mitochondria in axons.

Authors:  Philip D Campbell; Kimberle Shen; Matthew R Sapio; Thomas D Glenn; William S Talbot; Florence L Marlow
Journal:  J Neurosci       Date:  2014-10-29       Impact factor: 6.167

4.  Delivery of GABAARs to synapses is mediated by HAP1-KIF5 and disrupted by mutant huntingtin.

Authors:  Alison E Twelvetrees; Eunice Y Yuen; I Lorena Arancibia-Carcamo; Andrew F MacAskill; Philippe Rostaing; Michael J Lumb; Sandrine Humbert; Antoine Triller; Frederic Saudou; Zhen Yan; Josef T Kittler
Journal:  Neuron       Date:  2010-01-14       Impact factor: 17.173

Review 5.  Evidence of kinesin heavy chain (KIF5A) involvement in pure hereditary spastic paraplegia.

Authors:  M Fichera; M Lo Giudice; M Falco; M Sturnio; S Amata; O Calabrese; S Bigoni; E Calzolari; M Neri
Journal:  Neurology       Date:  2004-09-28       Impact factor: 9.910

6.  Molecular motor KIF5A is essential for GABA(A) receptor transport, and KIF5A deletion causes epilepsy.

Authors:  Kazuo Nakajima; Xiling Yin; Yosuke Takei; Dae-Hyun Seog; Noriko Homma; Nobutaka Hirokawa
Journal:  Neuron       Date:  2012-12-06       Impact factor: 17.173

7.  Monoallelic and Biallelic Variants in EMC1 Identified in Individuals with Global Developmental Delay, Hypotonia, Scoliosis, and Cerebellar Atrophy.

Authors:  Tamar Harel; Gozde Yesil; Yavuz Bayram; Zeynep Coban-Akdemir; Wu-Lin Charng; Ender Karaca; Ali Al Asmari; Mohammad K Eldomery; Jill V Hunter; Shalini N Jhangiani; Jill A Rosenfeld; Davut Pehlivan; Ayman W El-Hattab; Mohammed A Saleh; Charles A LeDuc; Donna Muzny; Eric Boerwinkle; Richard A Gibbs; Wendy K Chung; Yaping Yang; John W Belmont; James R Lupski
Journal:  Am J Hum Genet       Date:  2016-03-03       Impact factor: 11.025

8.  Spastic paraplegia mutation N256S in the neuronal microtubule motor KIF5A disrupts axonal transport in a Drosophila HSP model.

Authors:  Petra Füger; Vrinda Sreekumar; Rebecca Schüle; Jeannine V Kern; Doychin T Stanchev; Carola D Schneider; Kathrin N Karle; Katharina J Daub; Vera K Siegert; Matthias Flötenmeyer; Heinz Schwarz; Ludger Schöls; Tobias M Rasse
Journal:  PLoS Genet       Date:  2012-11-29       Impact factor: 5.917

9.  Abnormal neurofilament transport caused by targeted disruption of neuronal kinesin heavy chain KIF5A.

Authors:  Chun-Hong Xia; Elizabeth A Roberts; Lu-Shiun Her; Xinran Liu; David S Williams; Don W Cleveland; Lawrence S B Goldstein
Journal:  J Cell Biol       Date:  2003-04-07       Impact factor: 10.539

10.  Extended phenotypic spectrum of KIF5A mutations: From spastic paraplegia to axonal neuropathy.

Authors:  Yo-Tsen Liu; Matilde Laurá; Joshua Hersheson; Alejandro Horga; Zane Jaunmuktane; Sebastian Brandner; Alan Pittman; Deborah Hughes; James M Polke; Mary G Sweeney; Christos Proukakis; John C Janssen; Michaela Auer-Grumbach; Stephan Zuchner; Kevin G Shields; Mary M Reilly; Henry Houlden
Journal:  Neurology       Date:  2014-07-09       Impact factor: 9.910

View more
  19 in total

Review 1.  The coming-of-age of nucleocytoplasmic transport in motor neuron disease and neurodegeneration.

Authors:  Paulo A Ferreira
Journal:  Cell Mol Life Sci       Date:  2019-02-11       Impact factor: 9.261

2.  Splice-site mutations in KIF5A in the Japanese case series of amyotrophic lateral sclerosis.

Authors:  Hiroya Naruse; Hiroyuki Ishiura; Jun Mitsui; Yuji Takahashi; Takashi Matsukawa; Kaori Sakuishi; Kiyotaka Nakamagoe; Zenshi Miyake; Akira Tamaoka; Jun Goto; Jun Yoshimura; Koichiro Doi; Shinichi Morishita; Tatsushi Toda; Shoji Tsuji
Journal:  Neurogenetics       Date:  2020-08-19       Impact factor: 2.660

Review 3.  An emerging role for mitochondrial dynamics in schizophrenia.

Authors:  Kyle H Flippo; Stefan Strack
Journal:  Schizophr Res       Date:  2017-05-16       Impact factor: 4.939

Review 4.  Motor Proteins and Spermatogenesis.

Authors:  Siwen Wu; Huitao Li; Lingling Wang; Nathan Mak; Xiaolong Wu; Renshan Ge; Fei Sun; C Yan Cheng
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  ALS-linked KIF5A ΔExon27 mutant causes neuronal toxicity through gain-of-function.

Authors:  Devesh C Pant; Janani Parameswaran; Lu Rao; Isabel Loss; Ganesh Chilukuri; Rosanna Parlato; Liang Shi; Jonathan D Glass; Gary J Bassell; Philipp Koch; Rüstem Yilmaz; Jochen H Weishaupt; Arne Gennerich; Jie Jiang
Journal:  EMBO Rep       Date:  2022-06-23       Impact factor: 9.071

Review 6.  Axon Biology in ALS: Mechanisms of Axon Degeneration and Prospects for Therapy.

Authors:  Michael P Coleman
Journal:  Neurotherapeutics       Date:  2022-10-07       Impact factor: 6.088

7.  Wide phenotypic spectrum in axonal Charcot-Marie-Tooth neuropathy type 2 patients with KIF5A mutations.

Authors:  Da Eun Nam; Da Hye Yoo; Sun Seong Choi; Byung-Ok Choi; Ki Wha Chung
Journal:  Genes Genomics       Date:  2017-10-10       Impact factor: 1.839

8.  A pan-cancer analysis reveals nonstop extension mutations causing SMAD4 tumour suppressor degradation.

Authors:  Sonam Dhamija; Chul Min Yang; Jeanette Seiler; Ksenia Myacheva; Maiwen Caudron-Herger; Angela Wieland; Mahmoud Abdelkarim; Yogita Sharma; Marisa Riester; Matthias Groß; Jochen Maurer; Sven Diederichs
Journal:  Nat Cell Biol       Date:  2020-07-27       Impact factor: 28.213

9.  A novel mutation in KIF5A in a Malian family with spastic paraplegia and sensory loss.

Authors:  Cheick O Guinto; Salimata Diarra; Salimata Diallo; Lassana Cissé; Thomas Coulibaly; Seybou H Diallo; Abdoulaye Taméga; Ke-Lian Chen; Alice B Schindler; Koumba Bagayoko; Assiatou Simaga; Craig Blackstone; Kenneth H Fischbeck; Guida Landouré
Journal:  Ann Clin Transl Neurol       Date:  2017-03-21       Impact factor: 4.511

10.  Hot-spot KIF5A mutations cause familial ALS.

Authors:  David Brenner; Rüstem Yilmaz; Kathrin Müller; Torsten Grehl; Susanne Petri; Thomas Meyer; Julian Grosskreutz; Patrick Weydt; Wolfgang Ruf; Christoph Neuwirth; Markus Weber; Susana Pinto; Kristl G Claeys; Berthold Schrank; Berit Jordan; Antje Knehr; Kornelia Günther; Annemarie Hübers; Daniel Zeller; Christian Kubisch; Sibylle Jablonka; Michael Sendtner; Thomas Klopstock; Mamede de Carvalho; Anne Sperfeld; Guntram Borck; Alexander E Volk; Johannes Dorst; Joachim Weis; Markus Otto; Joachim Schuster; Kelly Del Tredici; Heiko Braak; Karin M Danzer; Axel Freischmidt; Thomas Meitinger; Tim M Strom; Albert C Ludolph; Peter M Andersen; Jochen H Weishaupt
Journal:  Brain       Date:  2018-03-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.